Ashfield, part of UDG Healthcare, a leading international healthcare services provider, has announced the appointment of Pierre Van Weperen as Commercial and Patient Solut
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS